Zhejiang Hisun Pharma teams up Sanofi on developing diabetes-related treatment

July 3 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd * Says signed non-binding MOU with Sanofi SA to set up a joint venture in China focusing on developing insulin and diabetes-related treatment Source text in Chinese: http://bit.ly/1LLDynM Further company coverage: (Reporting by Hong Kong newsroom)